These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33649700)

  • 1. Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19.
    Sharma T; Abohashrh M; Baig MH; Dong JJ; Alam MM; Ahmad I; Irfan S
    Saudi J Biol Sci; 2021 May; 28(5):3152-3159. PubMed ID: 33649700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").
    Cayona R; Creencia E
    Med Chem; 2022; 18(3):364-381. PubMed ID: 34148541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach.
    Indu P; Rameshkumar MR; Arunagirinathan N; Al-Dhabi NA; Valan Arasu M; Ignacimuthu S
    J Infect Public Health; 2020 Dec; 13(12):1856-1861. PubMed ID: 33168456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series.
    Miglani V; Sharma P; Kumar Narula A
    Curr Comput Aided Drug Des; 2023 Aug; ():. PubMed ID: 37612857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
    Kundu D; Selvaraj C; Singh SK; Dubey VK
    J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of Novel Lichen Compounds as Inhibitors of SARS-CoV-2 Mpro: Ligand-Based Design, Molecular Dynamics, and ADMET Analyses.
    Gupta A; Sahu N; Singh AP; Singh VK; Singh SC; Upadhye VJ; Mathew AT; Kumar R; Sinha RP
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6386-6406. PubMed ID: 35921031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.
    Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R
    J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of potential inhibitors for SARS-CoV-2 Mpro considering its mutants via structure-based drug design, molecular docking, MD simulations, MM/PBSA, and DFT calculations.
    Ghasemlou A; Uskoković V; Sefidbakht Y
    Biotechnol Appl Biochem; 2023 Feb; 70(1):439-457. PubMed ID: 35642754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.
    Byadi S; Oblak D; Kassmi Y; Sadik K; Hachim ME; Podlipnik Č; Aboulmouhajir A
    J Biomol Struct Dyn; 2023 Apr; 41(7):2900-2910. PubMed ID: 35168469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening based on the structure of more than 10
    Nabati F; Kamyabiamineh A; Kosari R; Ghasemi F; Seyedebrahimi S; Mohammadi S; Moradi M
    Inform Med Unlocked; 2022; 35():101134. PubMed ID: 36406927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors.
    Jiménez-Alberto A; Ribas-Aparicio RM; Aparicio-Ozores G; Castelán-Vega JA
    Comput Biol Chem; 2020 Oct; 88():107325. PubMed ID: 32623357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors.
    Ghosh K; Amin SA; Gayen S; Jha T
    J Mol Struct; 2021 Jan; 1224():129026. PubMed ID: 32834115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
    Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
    J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational selection of flavonoid compounds as inhibitors against SARS-CoV-2 main protease, RNA-dependent RNA polymerase and spike proteins: A molecular docking study.
    Rameshkumar MR; Indu P; Arunagirinathan N; Venkatadri B; El-Serehy HA; Ahmad A
    Saudi J Biol Sci; 2021 Jan; 28(1):448-458. PubMed ID: 33110386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
    Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
    Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SARS-CoV-2 M
    Đukić I; Kaličanin N; Sencanski M; Pajovic SB; Milicevic J; Prljic J; Paessler S; Prodanović R; Glisic S
    Front Biosci (Landmark Ed); 2023 Jan; 28(1):8. PubMed ID: 36722278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness/ADMET studies.
    Rudrapal M; Gogoi N; Chetia D; Khan J; Banwas S; Alshehri B; Alaidarous MA; Laddha UD; Khairnar SJ; Walode SG
    Saudi J Biol Sci; 2022 Apr; 29(4):2432-2446. PubMed ID: 34924801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potent compounds against SARs-CoV-2: An in-silico based drug searching against Mpro.
    Hassam M; Bashir MA; Shafi S; Zahra NU; Khan K; Jalal K; Siddiqui H; Uddin R
    Comput Biol Med; 2022 Dec; 151(Pt A):106284. PubMed ID: 36370580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study.
    Baig MH; Sharma T; Ahmad I; Abohashrh M; Alam MM; Dong JJ
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33802860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.